Talhia Tuck
Director/Board Member bei TELOMIR PHARMACEUTICALS, INC.
Vermögen: 273 222 $ am 31.03.2024
Profil
Talhia T.
Tuck is an Independent Director at Telomir Pharmaceuticals, Inc. She previously worked as an Associate Director-Admissions at Georgetown University from 2016 to 2019.
She also served as an Independent Director at MIRA Pharmaceuticals, Inc. from 2021 to 2024.
Additionally, Talhia held the position of VP-Communications & Investor Relations at Rock Creek Pharmaceuticals, Inc. She completed her undergraduate degree at Harvard University in 2000 and obtained her graduate degree from Harvard Law School in 2010.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 29.03.2024 | 48 781 ( 0,16% ) | 251 222 $ | 31.03.2024 | |
| 03.08.2023 | 20 000 ( 0,14% ) | 22 000 $ | 31.03.2024 |
Aktive Positionen von Talhia Tuck
| Unternehmen | Position | Beginn |
|---|---|---|
| TELOMIR PHARMACEUTICALS, INC. | Director/Board Member | 01.11.2022 |
Ehemalige bekannte Positionen von Talhia Tuck
| Unternehmen | Position | Ende |
|---|---|---|
| MIRA PHARMACEUTICALS, INC. | Director/Board Member | 09.03.2024 |
| Georgetown University | Corporate Officer/Principal | 01.01.2019 |
| ROCK CREEK PHARMACEUTICALS, INC. | Investor Relations Contact | 01.04.2014 |
| ROCK CREEK PHARMACEUTICALS, INC. | Investor Relations Contact | - |
Ausbildung von Talhia Tuck
| Harvard University | Undergraduate Degree |
| Harvard Law School | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MIRA PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Rock Creek Pharmaceuticals, Inc.
 Rock Creek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rock Creek Pharmaceuticals, Inc. is an early stage life science company, which engages in the discovery, development, and commercialization of new drugs, formulations, and compounds that provide therapies for chronic and acute inflammatory diseases. It focuses on small molecule therapeutics that exhibit anti-inflammatory pharmacological characteristics. The company was founded by Jonnie R. Williams, Sr. on June 24, 1985 and is headquartered in Sarasota, FL. | Health Technology |
| Telomir Pharmaceuticals, Inc. |
